The concurrent chemoradiation paradigm—general principles
Top Cited Papers
- 1 February 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Oncology
- Vol. 4 (2), 86-100
- https://doi.org/10.1038/ncponc0714
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Palifermin Reduces Patient-Reported Mouth and Throat Soreness and Improves Patient Functioning in the Hematopoietic Stem-Cell Transplantation SettingJournal of Clinical Oncology, 2006
- O-038 Initial pulmonary toxicity evaluation of chemoradiotherapy (CRT) utilizing 74 Gy 3-dimensional (3-D) thoracic radiation in stage III non-small cell lung cancer (NSCLC): A Cancer and Leukemia Group B (CALGB) randomized phase II trialLung Cancer, 2005
- Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemotherapy: Clinical ImplicationsJournal of Clinical Oncology, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Rationale for chemoradiotherapyInternational Journal of Clinical Oncology, 2004
- Epidermal growth factor receptor and response of head-and-neck carcinoma to therapyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted AgentsJournal of Clinical Oncology, 2003
- Radiation Therapy and Hydroxyurea Followed by the Combination of 6-Thioguanine and BCNU for the Treatment of Primary Malignant Brain TumorsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- In vitro evaluation of temozolomide combined with X-irradiationAnti-Cancer Drugs, 1997